Vaccination therapy for Alzheimer's disease

Clinical Neurology

Volumn 49, Issue 11, 2009, Pages 848-850

  Tabira, Takeshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Amyloid; Antibody therapy; Helper T cell; Viral vector

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; TAPIR LIKE ANTIBODY; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); AN-1792; BAPINEUZUMAB; GLATIRAMER; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE FRAGMENT;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; AMYLOID PLAQUE; BINDING AFFINITY; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; PASSIVE IMMUNIZATION; TH2 CELL; VACCINATION; ADENO ASSOCIATED VIRUS; IMMUNOLOGY; REVIEW;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; DEPENDOVIRUS; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; TH2 CELLS; VACCINATION;

EID: 77956206153     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.49.848     Document Type: Conference Paper

References (10)

1. Schenk D, Barbour R, Dunn W, et al: Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177 (Pubitemid 29327547)
2. Bard F, Cannon C, Barbour R, et al: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-919 (Pubitemid 30644751)
3. Hock C, Konietzko U, Streffer JR, et al: Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 2003; 38: 547-554 (Pubitemid 36645030)
4. Wang J, Hara H, Makifuchi T, et al: Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta. J Alzheimers Dis 2008; 14: 161-173 (Pubitemid 352040035)
5. Kellner A, Matschke J, Bernreuther C, et al: Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol 2009; 65: 24-31
6. Tabira T: Decorated plaques in Alzheimer's disease. Ann Neurol 2009; 65: 4-6
7. Okura Y, Miyakoshi A, Kohyama K, et al: Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: longterm effects and safety. Proc Natl Acad Sci USA 2006; 103: 9619-9624 (Pubitemid 43955874)
8. Butovsky O, Koronyo-Hamaoui M, Kunis G, et al: Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A 2006; 103: 11784-11789 (Pubitemid 44182528)
9. Mouri A, Noda Y, Hara H, et al: Oral vaccination with a viral vector containing Aβ cDNA attenuates age-related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 2007; 21: 2135-2148 (Pubitemid 47026449)
10. Holmes C, Boche D, Wilkinson D, et al: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008; 372: 216-223 (Pubitemid 351978111)